- 现金
- 62111 元
- 精华
- 26
- 帖子
- 30437
- 注册时间
- 2009-10-5
- 最后登录
- 2022-12-28
|
Ned Tijdschr Geneeskd. 2009;153:A905.
[Management and treatment of pregnant women with hepatitis B]
[Article in Dutch]
Boland GJ, Veldhuijzen IK, Janssen HL, van der Eijk AA, Wouters MG, Boot HJ.
Nationaal Hepatitis Centrum, Amersfoort, The Netherlands. [email protected]
Every year about 800 chronic hepatitis B infections are identified in the
Netherlands as result of the nationwide pregnancy screening. About one-third
of these are newly discovered infections. In recent years there has been a
marked increase in treatment options for chronic hepatitis B infection using
antiviral drugs. Pregnant women can now be treated as well. A pregnant woman
with a low viral load does not require immediate treatment, as due to the
passive immunisation and active vaccination of the newborn the chances of
infection due to perinatal transmission are negligible. Treatment of the
mother can therefore be postponed until after the birth. However, when the
pregnant woman has a high viral load (>10(9) copies/ml in serum), perinatal
transmission can still occur despite vaccination of the newborn. In these
women, antiviral treatment in the last trimester of the pregnancy should be
considered. At present, experience of treating HBV-infected pregnant women has
only been gained with lamivudine. It appears that the quantity of circulating
virus decreases due to the treatment. Treatment should always be supervised by
a gastroenterologist or an infectiologist. Detection, referral and treatment
of the mother and child are described in several guidelines that have recently
been updated and harmonized with each other. These include a practice
guideline from the Dutch College of General Practitioners, a guideline from
the Centre for Infectious Disease Control of the National Institute for Public
Health and the Environment, and a guideline from the Netherlands Society of
Gastroenterology.
PMID: 20051170 [PubMed - in process |
|